Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 6, 2007, Pages 715-719

  Ayhan, Ali ^a   Guven, Emine Seda Guvendag ^a   Guven, Suleyman ^a,b   Sakinci, Mehmet ^a   Dogan, N Utku ^a   Kucukali, Turkan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Lichen sclerosus; Medical treatment; Mixed disease; Vulvar non neoplastic disease

Indexed keywords

CLIOQUINOL PLUS FLUMETASONE PIVALATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; PETROLATUM; TESTOSTERONE PROPIONATE;

ADULT; ARTICLE; BIOPSY; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; SQUAMOUS CELL HYPERPLASIA; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; VULVA; VULVECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CLOBETASOL; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERPLASIA; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TESTOSTERONE PROPIONATE; VULVAR LICHEN SCLEROSUS;

EID: 34249051089     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701292809     Document Type: Article

References (16)

1. Bohl TG. Overview of vulvar pruritus through the life cycle. Clin Obstet Gynecol. 2005;48:786-807.
2. MacLean AB, Reid WM. Benign and premalignant disease of the vulva. Br J Obstet Gynaecol. 1995;102:359-63.
3. New nomenclature for vulvar disease. Report of the Committee on Terminology of the International Society for the Study of Vulvar Disease. J Reprod Med. 1990;35:483-4.
4. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50:807-10.
5. Rivlin M. Nonneoplastic epithelial disorders of the vulva in eMedicine Specialties. Last update February 15, 2005.
6. Ayhan A, Yuce K, Urman B, Ayhan A, Gokoz A. Vulvar dystrophies: an evaluation. Aust N Z J Obstet Gynaecol. 1989;29:250-2.
7. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol. 2005;48:808-17.
8. Cattaneo A, De Marco A, Sonni L, Bracco GL, Carli P, Taddei GL. [Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region]. Minerva Ginecol. 1992;44:567-71.
9. Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol. 2004;5:105-25.
10. Cattaneo A, Bracco GL, Maestrini G, Carli P, Taddei GL, Colafranceschi M, et al. Lichen sclerosus and squamous hyperplasia of the vulva. A clinical study of medical treatment. J Reprod Med. 1991;36:301-5.
11. Ayhan A, Tuncer ZS, Kaya H. Vulvar dystrophy: an evaluation of 285 cases. Eur J Gynaecol Oncol. 1997;18:139-40.
12. Zorlu CG, Cobanoglu O. Medical treatment of squamous hyperplasia and lichen sclerosus of the vulva. Int J Gynaecol Obstet. 1995;51:235-8.
13. Clark TJ, Etherington IJ, Luesley DM. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids. J Reprod Med. 1999;44:958-62.
14. Kaufman RH, Gardner HL, Brown D Jr, Beyth Y. Vulvar dystrophies: an evaluation. Am J Obstet Gynecol. 1974;120:363-7.
15. Micheletti L, Borgno G, Barbero M, Preti M, Cavanna L, Benedetto C, et al. Cellular atypia in vulvar dystrophies. J Reprod Med. 1988;33:539-41.
16. Hart WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol. 1975;45:369-77.